Xiao-Yu Zhuang
Overview
Explore the profile of Xiao-Yu Zhuang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu C, Zhang J, Zhuang X, Zhao Z, Qian X, Chen Y
Phytomedicine
. 2025 Feb;
139:156455.
PMID: 39922150
Purpose: To study the pharmacological effects of solasonine (Sol) in inhibiting non-small cell lung cancer (NSCLC) metastasis. Methods: The pharmacological effects of solasonine were examined in vitro by continuous induction...
2.
Xu D, Chen L, Zhuang X, Han H, Mo M
Front Oncol
. 2024 Aug;
14:1394260.
PMID: 39087027
Penile cancer is a rare malignant tumor of the male urinary system. The treatment benefit of standard first-line chemotherapy is not ideal for patients with locally advanced or metastatic lymph...
3.
Xu D, Zhuang X, Ma H, Li Z, Wei L, Luo J, et al.
Cancer Med
. 2024 Jul;
13(14):e70025.
PMID: 39003681
Background: Lymphatic metastasis is the major challenge in the treatment of penile cancer. The prognosis of individuals with lymphatic metastasis is extremely poor. Therefore, early identification of disease progression and...
4.
Xu D, Chen L, Zhuang X, Han H, Mo M
Int J Med Sci
. 2024 May;
21(6):1176-1186.
PMID: 38774752
To uncover the potential significance of JAK-STAT-SOCS1 axis in penile cancer, our study was the pioneer in exploring the altered expression processes of JAK-STAT-SOCS1 axis in tumorigenesis, malignant progression and...
5.
Zhuang X, Li M, Xu D, Lin S, Yang Z, Xu T, et al.
Health Sci Rep
. 2024 Feb;
7(2):e1884.
PMID: 38352696
Background: The effect of pain genes (NAV1, EHMT2, SP1, SLC6A4, COMT, OPRM1, OPRD1, CYP2D6, and CYP3A4) have not been reported previously in kidney renal clear cell carcinoma (KIRC) patients and...
6.
Zhang Y, Zhu G, Liu W, Chen X, Xie Y, Xu J, et al.
J Med Virol
. 2023 Nov;
95(11):e29208.
PMID: 37947293
The main proteases (M ) are highly conserved cysteine-rich proteins that can be covalently modified by numerous natural and synthetic compounds. Herein, we constructed an integrative approach to efficiently discover...
7.
Zhang Y, Zhu G, Liu W, Xiong Y, Hu Q, Zhuang X, et al.
Phytomedicine
. 2023 Apr;
114:154796.
PMID: 37037086
Background: The 3C-like proteases (3CLs) are cysteine-rich homodimeric proteins and can be covalently modified by numerous natural and synthetic compounds, which in turn, block the proteolytic activity or the formation...